Chris M. Calcaterra

Mr. Calcaterra has served as the executive vice president, global commercial operations since April 2022. He previously served as the chief operating officer from February 2017 to March 2022, and as the chief commercial officer from April 2008 to January 2017. Mr. Calcaterra has more than 30 years of experience in the ophthalmic medical technology industry. Prior to joining the Company, Mr. Calcaterra was senior vice president at Advanced Medical Optics, Inc. (acquired by Abbott Laboratories), and was responsible for its cataract business. Prior to that position, Mr. Calcaterra held increasingly responsible vice president positions in a variety of sales and marketing roles at Advanced Medical Optics, Inc., as well as its predecessor surgical division business at Allergan, Inc. Mr. Calcaterra has a B.S. from Miami University and an M.B.A. from Xavier University, and he was previously a board member of WaveTec Vision Systems, Inc. (acquired by Novartis).